about
In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer.Selectins-an emerging target for drug delivery.Human respiratory epithelial cell culture for drug delivery applications.Selectins--potential pharmacological targets?The particle has landed--characterizing the fate of inhaled pharmaceuticals.Nanodrug applications in photodynamic therapy.In search of the fibrotic epithelial cell: opportunities for a collaborative network.Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery.Liposomal delivery of proteins and peptides.Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro.Transport mechanisms at the pulmonary mucosa: implications for drug delivery.Functional expression of nicotine influx transporter in A549 human alveolar epithelial cells.Organic cation transporter function in different in vitro models of human lung epithelium.Functional Expression of PEPT2 in the Human Distal Lung Epithelial Cell Line NCl-H441.Materials and methods for delivery of biological drugs.The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier.Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.The verapamil transporter expressed in human alveolar epithelial cells (A549) does not interact with β2-receptor agonists.Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells.In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.Atomic force microscopy and high-content analysis: two innovative technologies for dissecting the relationship between epithelial-mesenchymal transition-related morphological and structural alterations and cell mechanical properties.Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.Investigations into the fate of inhaled salmon calcitonin at the respiratory epithelial barrier.Cytoskeletal re-arrangement in TGF-β1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis.Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells.Nanoparticles attenuate P-glycoprotein/MDR1 function in A549 human alveolar epithelial cells.RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models.RBL-2H3 cells are an imprecise model for mast cell mediator release.Toll-like receptors and RBL-2H3 mast cells.Characterisation of the R3/1 cell line as an alveolar epithelial cell model for drug disposition studies.Inhibition of LFA-1 mediated T-cell motility by naphthoquinones.In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T.Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-.Salbutamol is actively absorbed across human bronchial epithelial cell layers.
P50
Q33256336-919D72A4-1865-4AAD-8E5C-E29EDE91D758Q33576663-035F5B44-FDEE-4D06-A2CF-8C776D15F609Q34321160-F9BE5A9A-808C-4811-AC76-9A04981C7472Q34480269-89D6AED7-405D-4A6F-B096-8AC712B93C55Q35669922-7E0D5020-F20C-46AE-8E26-ECD23E0DD6C0Q36153616-2497214F-E6FC-44D3-BDF8-63869EEFDD10Q36630618-20F0B25D-292A-4C3E-B254-7459164C7F5FQ37816440-4475271F-3374-48A8-9B61-9367815DBF72Q37844844-B7974213-0D5D-4240-8C47-6584D7FDE95CQ37890719-470F98B2-4F9C-4A4F-AB41-8AFF27E61E5EQ38030026-4E017F51-74AF-4E25-9305-1CD7710FCD8BQ38054780-A96E9EE3-8DE1-4721-B1EE-4E3C59C394D6Q38704919-A8C1CDA2-15E6-4E14-96F6-827A6E5F9853Q38747965-B134D773-7EF1-48AE-A844-6D5BF1FF00CBQ38797723-75B47251-F4F6-4881-BA22-FAC86B1ACA52Q38841891-09367946-56EA-423E-B9DA-FB2DAACA8BF0Q38853663-BC5106FB-CB27-4B9E-894C-F68FF5A02675Q38987392-6DCA3A0A-E83B-419B-B8B2-092D8FF1FCF5Q39024240-8C2118CB-3DC2-4DB4-9537-B300E9E5C108Q39061441-8023036B-E682-4B2B-BE83-2E7EA4EDC7BAQ39134654-5B571BE1-D539-4E88-8ACA-4160A9CB739EQ39170220-03FC70C1-E1CA-40C3-93FA-A74A31D15E24Q39303560-881F0600-D135-48C1-9D8D-FC0F9EB7344BQ39378126-7EC6D2A4-7EF6-4947-9CC3-5A730ED84431Q39398633-B6BB694E-34E0-43FF-BAA9-85784997A27FQ39478497-617C035F-346C-47A3-B9E8-F7E667F94177Q39481109-E7268E86-F415-4409-8FE0-B24943AE78D9Q39494684-3097405F-4E51-4A5A-AE2C-7D02003C4F68Q39506833-A4DAFD55-75D8-403B-B98C-B2F303B4613FQ39600783-40EF6055-01B5-476F-A99A-D073406664E0Q39629392-870177EE-F49F-44B8-A03C-025FD2A72C75Q39858445-AF23F231-83C5-4153-B621-D5B495AE62D4Q39870552-4F404B1A-02BF-456A-8109-6311D81EA479Q39875491-8A5DD6EA-E7AA-4150-B054-1DF8566A8494Q39902443-B1F48F14-5E96-4726-BDC5-8BD843F27F85Q39956018-AA2FF5B2-1EA3-40C4-897C-F70230D2FADBQ40001746-3FDDBC8F-5D82-4B24-B0C6-66029738ED01Q40143803-07BDC3F1-4F33-442D-8CDF-4B154ADFCE37Q40357946-C152C9DD-48A4-4809-9082-619414F8DC1BQ40459333-FCCEF212-32D0-48B1-9A4B-A0007D075416
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Carsten Ehrhardt
@ast
Carsten Ehrhardt
@en
Carsten Ehrhardt
@es
Carsten Ehrhardt
@nl
Carsten Ehrhardt
@sl
type
label
Carsten Ehrhardt
@ast
Carsten Ehrhardt
@en
Carsten Ehrhardt
@es
Carsten Ehrhardt
@nl
Carsten Ehrhardt
@sl
prefLabel
Carsten Ehrhardt
@ast
Carsten Ehrhardt
@en
Carsten Ehrhardt
@es
Carsten Ehrhardt
@nl
Carsten Ehrhardt
@sl
P214
P244
P1053
B-1259-2010
P106
P1153
57074940200
P21
P213
0000 0001 1617 0117
P214
P244
no2008049271
P31
P3829
P496
0000-0003-0730-1829
P734
P735
P7859
lccn-no2008049271